Effects of somatostatin analog treatment on cardiovascular parameters in patients with acromegaly: A systematic review

BACKGROUND: There is a belief that in patients with acromegaly, first-generation somatostatin analogs (SSAs) might improve cardiovascular (CV) structure and function. However, most published clinical trials involved only a few patients and their results are rather variable. We aimed to conduct a sys...

Descripción completa

Detalles Bibliográficos
Autores principales: Heidarpour, Maryam, Shafie, Davood, Aminorroaya, Ashraf, Sarrafzadegan, Nizal, Farajzadegan, Ziba, Nouri, Rasool, Najimi, Arash, Dimopolou, Christina, Stalla, Gunter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2019
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6521613/
https://www.ncbi.nlm.nih.gov/pubmed/31143230
http://dx.doi.org/10.4103/jrms.JRMS_955_18

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6521613/
https://www.ncbi.nlm.nih.gov/pubmed/31143230
http://dx.doi.org/10.4103/jrms.JRMS_955_18

Ejemplares similares